Perspective Therapeutics (NYSE:CATX) Price Target Cut to $15.00 by Analysts at Royal Bank of Canada
Perspective Therapeutics (NYSE:CATX – Free Report) had its price target cut by Royal Bank of Canada from $16.00 to $15.00 in a research note released on Thursday morning,Benzinga reports. They currently have an outperform rating on the stock. Several other equities research analysts also recently weighed in on the stock. HC Wainwright reaffirmed a “buy” […]
Perspective Therapeutics (NYSE:CATX – Free Report) had its price target cut by Royal Bank of Canada from $16.00 to $15.00 in a research note released on Thursday morning,Benzinga reports. They currently have an outperform rating on the stock. Several other equities research analysts also recently weighed in on the stock. HC Wainwright reaffirmed a “buy” […]
